Duffy, A., Makarova‐Rusher, O., Ulahannan, S., Rahma, O., Fioravanti, S., Walker, M., Abdullah, S., Raffeld, M., Anderson, V., Abi‐Jaoudeh, N., Levy, E., Wood, B., Lee, S., Tomita, Y., Trepel, J., Steinberg, S., Revenko, A., MacLeod, A., Peer, C., Figg, W., & Greten, T. (n.d.). modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer. International journal of cancer, 139(7), 1648–1657. http://access.bl.uk/ark:/81055/vdc_100034747801.0x000049